An ovary-on-a-chip to identify ovarian toxicity
用于识别卵巢毒性的卵巢芯片
基本信息
- 批准号:10210586
- 负责人:
- 金额:$ 35.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-20 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAlginatesAnimal TestingAnimalsArchitectureBiological AssayChemicalsConsumptionCryopreservationDevelopmentEndocrine DisruptorsEnvironmentEnvironmental ImpactExhibitsFemaleFertilizationGerm CellsGoalsGoldGonadal Steroid HormonesGonadal structureGrowing FollicleGrowthHealthHepaticHepatocyteHormone imbalanceHormone secretionHumanHydrogelsImageIn VitroInfertilityInjuryLaboratoriesLiverLuteinizationMenstrual cycleMethodsMicroarray AnalysisMicrofluidicsMicroscopyModelingMolecularMolecular ProfilingMonitorMorphologyMusOocytesOrganOvarianOvarian FollicleOvarian TissueOvaryOvulationPatternPharmacologic SubstancePhysiological ProcessesPremature MenopausePremature Ovarian FailurePrimordial FollicleResearchRiskRisk AssessmentSignal TransductionSystemTestingTimeToxic Environmental SubstancesToxic effectToxicity TestsToxinTransgenic MiceTranslatingUnited States National Institutes of HealthWomanagedbasebiobankconsumer productcostenvironmental chemicalgirlsharmful algal bloomsin vitro Modelinnovationinnovative technologiesinsightliver metabolismmicrofluidic technologyneonatal micenoveloocyte maturationovotoxicitypeptide hormoneprepubertypreservationreproductivereproductive outcomereproductive toxicityscreeningtoxicanttranscriptome sequencingvalidation studies
项目摘要
PROJECT SUMMARY
The ovary and its functional unit, the follicles, are critical for the secretion of sex steroids and peptide hormones
as well as the maturation and release of oocytes for ovulation and fertilization. Increasing evidence has revealed
that a wide spectrum of environmental chemicals and pharmaceuticals cause ovarian toxicity (ovotoxicity) and
heighten the risk of premature ovarian failure, hormonal imbalance, and infertility in both reproductive aged
women and prepubertal girls. With over 85,000 chemicals used in consumer products as well as emerging
contaminants such as harmful algal bloom (HAB) toxins, there are few means to screen for potential toxicity to
the ovaries. We have previously developed an ovary-on-a-chip (OvaryChip) that maintains the 3D architecture
of follicles and produces human menstrual cycle-like follicle development, hormone secretion, oocyte maturation,
ovulation, and luteinization. Yet, one remaining challenge of this innovative model is the critical need to
accelerate throughput. The central hypothesis of this research is that in vitro microfluidic follicular
cultures can be used to identify novel mechanisms of ovarian toxicity for environmental toxicants. In
Aim 1, we will integrate follicle vitrification, 3D in vitro follicle growth, and a new OvaryChip with high-content
culture and imaging to develop a high-throughput ovotoxicity testing of growing follicles. In Aim 2, we will develop
a new OvaryChip for ovotoxicity testing of primordial follicles by using triple transgenic mouse ovarian explants.
In Aim 3, we will develop a liver-ovary-on-a-chip to incorporate liver metabolism into ovotoxicity testing. In these
studies, we will assess follicle and oocyte reproductive outcomes at morphological, functional, and molecular
levels for 1) chemicals with known ovotoxicities (validation studies) and 2) novel HAB toxins alone and in mixtures.
These studies are critically significant because the OvaryChip models will (1) translate a bench assay for a single
compound into a robust high-throughput ovotoxicity screening platform; (2) reveal novel insight into chemical-
induced ovotoxicity (stage- and metabolite-dependent mechanisms); (3) minimize the cost and use of whole
animals; and (4) prioritize chemicals of high ovotoxicity concern, including HAB toxins, for further risk assessment.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shuo Xiao其他文献
Shuo Xiao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shuo Xiao', 18)}}的其他基金
Ovarian impacts of extreme heat and co-exposure to climate change-induced harmful algal bloom toxins (Admin Supplement to R01ES032144)
极端高温和共同暴露于气候变化引起的有害藻华毒素对卵巢的影响(R01ES032144 的管理补充)
- 批准号:
10838834 - 财政年份:2023
- 资助金额:
$ 35.44万 - 项目类别:
An ovary-on-a-chip to identify ovarian toxicity
用于识别卵巢毒性的卵巢芯片
- 批准号:
10625482 - 财政年份:2021
- 资助金额:
$ 35.44万 - 项目类别:
An ovary-on-a-chip to identify ovarian toxicity
用于识别卵巢毒性的卵巢芯片
- 批准号:
10490265 - 财政年份:2021
- 资助金额:
$ 35.44万 - 项目类别:
Development of a High-Throughput Platform for Screening Ovotoxic Chemicals (K01ES030014)
开发用于筛选卵毒性化学品的高通量平台(K01ES030014)
- 批准号:
10164140 - 财政年份:2020
- 资助金额:
$ 35.44万 - 项目类别:
Development of a High-Throughput Platform for Screening Ovotoxic Chemicals (K01ES030014)
开发用于筛选卵毒性化学品的高通量平台(K01ES030014)
- 批准号:
10269942 - 财政年份:2020
- 资助金额:
$ 35.44万 - 项目类别:
相似海外基金
Étude des interactions de sorption et de séquestration de polluants sur des alginates
海藻酸盐污染物吸附与封存相互作用研究
- 批准号:
571945-2022 - 财政年份:2022
- 资助金额:
$ 35.44万 - 项目类别:
University Undergraduate Student Research Awards
Engineering an Islet Thread from zwitterionically modified alginates for type 1 diabetes
利用两性离子改性藻酸盐设计胰岛丝,用于治疗 1 型糖尿病
- 批准号:
9910390 - 财政年份:2018
- 资助金额:
$ 35.44万 - 项目类别:
Engineering an Islet Thread from zwitterionically modified alginates for type 1 diabetes
利用两性离子改性藻酸盐设计胰岛丝,用于治疗 1 型糖尿病
- 批准号:
10402773 - 财政年份:2018
- 资助金额:
$ 35.44万 - 项目类别:
ALGIPRO - Alginates by Production Scale Fermentation and Epimerisation
ALGIPRO - 通过生产规模发酵和差向异构化生产海藻酸盐
- 批准号:
102148 - 财政年份:2016
- 资助金额:
$ 35.44万 - 项目类别:
Collaborative R&D
Bioactive Alginates and Obesity
生物活性藻酸盐与肥胖
- 批准号:
BB/G00563X/1 - 财政年份:2008
- 资助金额:
$ 35.44万 - 项目类别:
Research Grant